Androgens, exercise capacity, and muscle function in cystic fibrosis

Chest

Volumn 134, Issue 6, 2008, Pages 1258-1264

  Barry, Peter James ^a   Waterhouse, Deirdre F ^a   Reilly, Claire M ^a   McKenna, T Joseph ^a   McKone, Edward F ^a   Gallagher, Charles G ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Androgens; Cystic fibrosis; Exercise capacity; Muscle strength; Testosterone

Indexed keywords

ALBUMIN; ANDROGEN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CYSTIC FIBROSIS; EXERCISE; HAND GRIP; HORMONE DETERMINATION; HUMAN; MALE; MUSCLE FUNCTION; MUSCLE STRENGTH; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUADRICEPS FEMORIS MUSCLE; VENOUS BLOOD;

EID: 57349192835     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-1091     Document Type: Article

References (45)

1. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003; 168:918-951
2. Pinet C, Cassart M, Scillia P, et al. Function and bulk of respiratory and limb muscles in patients with cystic fibrosis. Am J Respir Crit Care Med 2003; 168:989-994
3. Lands L, Desmond K, Demizio D, et al. The effects of nutritional status and hyperinflation on respiratory muscle strength in children and young adults. Am Rev Respir Dis 1990; 146:1506-1509
4. McKone EF, Barry SC, Fitzgerald MX, et al. Reproducibility of maximal exercise ergometer testing in patients with cystic fibrosis. Chest 1999; 116:363-368
5. Orenstein DM. Exercise testing in cystic fibrosis. Pediatr Pulmonol 1998; 25:223-225
6. De Meer K, Gulmans VA, van Der Laag J. Peripheral muscle weakness and exercise capacity in children with cystic fibrosis. Am J Respir Crit Care Med 1999; 159:748-754
7. Nixon P, Orenstein D, Kelsey S, et al. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 1992; 327:1785-1788
8. Sharma R, Florea VG, Bolger AP, et al. Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax 2001; 56:746-750
9. Arora NS, Rochester DF. Respiratory muscle strength and maximal voluntary ventilation in undernourished patients. Am Rev Respir Dis 1982; 126:5-8
10. Coates AL, Boyce P, Muller D, et al. The role of nutritional status, airway obstruction, hypoxia and abnormalities in serum lipid composition in limiting exercise tolerance in children with cystic fibrosis. Bull Eur Physiopathol Respir 1979; 15:341-342
11. Dubois D. Disuse atrophy of skeletal muscle is associated with an increase in number of glucocorticoid receptors. Endocrinology 1980; 107:1649-1651
12. Barry SC, Gallagher CG. Corticosteroids and skeletal muscle function in cystic fibrosis. J Appl Physiol 2003; 95:1379-1384
13. Bhasin S, Woodhouse L, Storer TW. Proof of the effect of testosterone on skeletal muscle. J Endocrinol 2001; 170:27-38
14. Nierman DM, Mechanik JL. Hypotestosteronemia in chronically critically ill men. Crit Care Med 1999; 27:2418-2421
15. Rabkin JG, Wagner GJ, Rabkin R. A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Arch Gen Psychiatry 2000; 57:141-147
16. Van Vliet M, Spruit MA, Verleden G, et al. Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 172:1105-1111
17. Boas SR, Cleary DA, Lee PA, et al. Salivary testosterone levels in male adolescents with cystic fibrosis. Pediatr 1996; 97:361-363
18. Boas SR, Joswiak ML, Nixon PA, et al. Factors limiting anaerobic performance in adolescent males with cystic fibrosis. Med Sci Sports Exerc 1996; 28:291-298
19. Dodd JD, Barry SC, Daly LE, et al. Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis. J Cyst Fibros 2005; 4:101-105
20. McKone EF, Barry SC, Fitzgerald MX, et al. Role of arterial hypoxaemia and pulmonary mechanics in exercise limitation in adults with cystic fibrosis. J Appl Physiol 2005; 99:1012-1018
21. Dodd JD, Barry SC, Gallagher CG. Respiratory factors do not limit maximal symptom-limited exercise in patients with mild cystic fibrosis lung disease. Respir Physiol Neurobiol 2006; 152:176-185
22. McParland C, Resch EF, Krishnan B, et al. Inspiratory muscle weakness in chronic heart failure: role of nutrition and electrolyte status and systemic myopathy. Am J Respir Crit Care Med 1995; 151:1101-1107
23. McParland C, Krishnan B, Wang Y, et al. Inspiratory muscle weakness and dyspnea in chronic heart failure. Am Rev Respir Dis 1992; 146:467-472
24. Wang YM, Zintel T, Vasquez A, et al. Corticosteroid therapy and respiratory muscle function in humans. Am Rev Respir Dis 1991; 144:108-112
25. American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1995; 152:1107-1136
26. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84:3666-3672
27. Rosner W, Auchus RJ, Azziz R, et al. Position statement: utility, limitations, and pitfalls in measuring testosterone; and Endocrine Society position statement. J Clin Endocrinol Metab 2007; 92:405-413
28. Spruit MA, Thomeer MJ, Gosselink R, et al. Hypogonadism in male outpatients with sarcoidosis. Respir Med 2007; 101:2502-2510
29. Morley JE, Patrick P, Perry HM III. Evaluation of assays available to measure free testosterone. Metabolism 2002; 51:554-559
30. National Isometric Muscle Strength (NIMS) Database Consortium. Muscular weakness assessment: use of normal isometric strength data. Arch Phys Med Rehabil 1996; 77:1251-1255
31. Hamilton AL, Killian KJ, Summers E, et al. Muscle strength, symptom intensity and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995; 152:2021-2031
32. Clarke TJ, Freedman S, Campbell EJ, et al. The ventilatory capacity of patients with chronic airway obstruction. Clin Sci 1969; 36:307-316
33. Jones NL. Clinical exercise testing. 3rd ed. Philadelphia, PA: Saunders, 1988
34. Leifke E, Heilmann M, Puvogel N, et al. Sex steroids and body composition in men with cystic fibrosis. Eur J Endocrinol 2003; 148:551-557
35. Moorcroft AJ, Dodd ME, Webb AK. Exercise testing and prognosis in adult cystic fibrosis. Thorax 1997; 52:291-293
36. Laghi F. Low testosterone in chronic obstructive pulmonary disease: does it really matter? Am J Respir Crit Care Med 2005; 172:1069-1070
37. Landon C, Rosenfeld RG. Short stature and pubertal delay in male adolescents with cystic fibrosis: androgen treatment. Am J Dis Child 1984; 138:388-391
38. Snyder PJ. Hypogonadism in elderly men: what to do until evidence comes. N Engl J Med 2004; 350:440-442
39. Rhoden EL, Morgentaler A. Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med 2004; 350:482-492
40. Conway SP, Morton AM, Oldroyd B, et al. Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax 2000; 55:798-804
41. Hardin DS, Arumugam R, Seilheimer DK, et al. Normal bone mineral density in cystic fibrosis. Arch Dis Child 2001; 84:363-368
42. Cumming DC, Quigley ME, Yen SSC. Acute suppression of circulating testosterone levels by cortisol in men. J Clin Endocrinol Metab 1983; 57:671-673
43. Doerr P, Pirke KM. Cortisol-induced suppression of plasma testosterone in normal adults. J Clin Endocrinol Metab 1976; 43:622-629
44. Sakskura M, Takebe K, Nakagawa S. Inhibition of luteinizing hormone secretion induced by synthetic LHRH by long-term treatment with glucocorticoids in human subjects. J Clin Endocrinol Metab 1975; 40:774-779
45. Kamischke A, Kemper DE, Castel MA, et al. Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J 1998; 11:41-45